Autonomics and Orthostatic Hypotension¶
Emily Walsh
Background¶
- Orthostatic Hypotension (OH): SBP ↓ > 20 mmHg, DBP ↓ > 10 mmHg), or HR Increase > 30 within 3 min of standing up or head-up tilt to 60% on a tilt table
- Etiologies: Neurogenic OH (nOH) vs non-neurogenic OH
- nOH associated with autonomic failure
- Blunted tachycardia during hypotension characteristic of autonomic failure
- nOH: If HR rise is \<15
- nOH also associated with periods of high BP (supine hypertension)
- Ex: Neurodegenerative disease, neuropathy (diabetes, amyloid, paraneoplastic, etc)
- Other causes: volume depletion (most common), medications (diuretics, alpha-1 blockers, BB, etc), pump failure (severe AS, arrhythmia)
- nOH associated with autonomic failure
Evaluation¶
- Orthostatic vitals signs (checking supine, sitting, and standing with 5-minute wait in each position)
- Volume status exam
- Labs: CBC, CMP, EKG, TSH, B12, , LFTs
- Consider SPEP/UPEP, paraneoplastic panel, autonomic function testing depending on clinical context
Management¶
-
Conservative:
- TED hose and abdominal binder for ambulation
- Drink 16oz of fluid 15 min prior to standing
- If they have supine HTN, keep HOB 30-45 degrees at all times
- Add 2.3-4.6g of salt per day to diet (if no contraindications)
- Avoid high temperatures (which cause peripheral vasodilation)
-
Pharmacologic therapies (see table):
Drug | Dose | Mechanism | Side effects |
---|---|---|---|
Fludocortisone (Florinef) | 0.1mg QD ↑ by 0.1 mg Max: 0.3 mg QD |
Mineralocorticoid increase blood volume. Enhances sensitivity to circulating catecholamines | Edema HTN HypoK Do not use in CHF |
Midodrine | 2.5mg TID ↑ by 2.5mg Up to 10mg TID |
Peripheral-selective α1 agonist → constricts both aa & vv | Supine HTN Pilomotor reactions Pruritus GI upset Avoid in uncontrolled HTN, urinary retention, heart disease |
Droxidopa | 100mg ↑ by 100mg Up to 600mg TID |
NE precursor → carboxylated to NE. Can cross BBB. | Supine HTN, less than midodrine |
Atomoxetine | 10mg or 18mg | SNRI | Do not use w/ glaucoma or MAOI |
- Supine HTN therapies: transdermal nitroglycerin (preferred); minoxidil, hydralazine, or clonidine in select patients